Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. is a global biotechnology company focused on discovering, developing, and delivering novel medicines for people living with rare diseases. With a patient-centric approach, Amicus aims to develop innovative therapies to address significant unmet medical needs. The company's research and development efforts are directed towards a range of genetic diseases, including lysosomal storage disorders and muscular dystrophies. Amicus is committed to potentially transforming the lives of patients and their families through pioneering treatments.